With the widespread adoption of population-based breast cancer screening, ductal
carcinoma in situ (DCIS) has come to represent 20–25% of all breast neoplastic lesions …

Ductal carcinoma in situ (DCIS) is the most frequently diagnosed early‐stage breast cancer.
Only a subset of patients progress to invasive ductal carcinoma (IDC), and this presents a …

Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and,
despite treatment, a small fraction (5–10%) of DCIS patients develop subsequent invasive …

Cancer development is a complex process driven by inherited and acquired molecular and
cellular alterations. Prevention is the holy grail of cancer elimination, but making this a reality …

Purpose We evaluated the performance of the recently extended Breast and Ovarian
Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA version 5) in a …

Organoid cultures are increasingly used to model human cancers experimentally with a view
to tailoring personalized medicine and predicting drug responses. Breast cancer is no …

Purpose: High-grade serous epithelial ovarian cancer (HGS-EOC) is defined by high levels
of somatic copy-number alterations (SCNA) with marked spatial and temporal tumor …

Simple Summary Ductal carcinoma in situ (DCIS) is recognised as a precursor to invasive
breast cancer (IBC), while lobular carcinoma in situ (LCIS) is considered a risk factor for …

The evaluation and management of dermatologic diseases of the breast and nipple requires
an understanding of the unique anatomy of the breast and nipple and an awareness of the …

Breast cancer is the most common solid organ malignancy and the most frequent cause of
cancer death among women worldwide. Previous research has yielded insights into its …